Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response
Authors:
- 1 October 2014
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 328 (1) , 132-142
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP - 84381)
This publication has 54 references indexed in Scilit:
- GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activityExperimental Cell Research, 2014
- Salvage treatment in prostate cancer: a clinical approachExpert Review of Anticancer Therapy, 2013
- The evolving concept of cancer and metastasis stem cellsJournal of Cell Biology, 2012
- Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancerExperimental Cell Research, 2011
- Current status of experimental therapeutics for prostate cancerCancer Letters, 2008
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- Prostate cancerThe Lancet, 2008
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Metastatic Pancreatic Cancer: Emerging Strategies in Chemotherapy and Palliative CareThe Oncologist, 2003
- Dysregulated expression of growth factors and their receptors in the development of prostate cancerThe Prostate, 1999